Peng J, Lin Y, Sheng X, Yuan C, et al. Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer 2024;24:789.
PMID: 38956544